Equities research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Thursday. The firm set a “buy” rating on the stock.
Mannatech Stock Performance
NASDAQ MTEX opened at $11.16 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The firm has a market capitalization of $20.98 million, a price-to-earnings ratio of -13.78 and a beta of 1.02. The company’s fifty day moving average is $12.15 and its two-hundred day moving average is $9.20. Mannatech has a 52-week low of $6.75 and a 52-week high of $16.49.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. The company had revenue of $31.73 million during the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- High Flyers: 3 Natural Gas Stocks for March 2022
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Financial Services Stocks Investing
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What Are Dividend Challengers?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
